On June 5, Oscar Health rose 5.21% in regular trading, trading at $24.23/share, with trading volume of $66.51 million. The stock continued its upward momentum following Wells Fargo's rating upgrade.

Wells Fargo upgraded Oscar Health from Underweight to Equal Weight, raising its price target from $11 to $20. Analyst Stephen Baxter cited increased confidence in the Affordable Care Act marketplace, noting that enrollment figures and medical cost outcomes have both exceeded expectations. In Florida, which accounts for approximately 63.9% of Oscar Health's premium revenue, the medical loss ratio improved by 370 basis points year-over-year despite a 13.5% decline in membership.

The upgrade also effectively offset negative sentiment from CTO and co-founder Mario Schlosser's transition to an advisory role on June 2. Fundamentally, the company reported Q1 revenue of $4.65 billion, up 53% year-over-year, with net income of $679 million and EPS of $2.07, far surpassing the consensus estimate of $1.10.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)